Smartphone App for Anxiety and Depression

Overseen By Eilis I Murphy, BA

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: Trustees of Dartmouth College

Disqualifiers: Acute psychosis, Suicidal ideation, Bipolar, Cancer, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 12 weeks

102 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a prevention intervention study that will examine the efficacy of a smartphone-based intervention in decreasing cancer risk by targeting mental health risk factors of anxiety and depression.

Who Is on the Research Team?

Nicholas C Jacobson, PhD

Principal Investigator

Geisel School of Medicine, Dartmouth College

Are You a Good Fit for This Trial?

This trial is for middle-aged adults (40-64) who speak English, can consent, and have moderate to severe anxiety or depression but no cancer diagnosis. They must own a smartphone and not have had treatment changes in the last month.

Inclusion Criteria

Fluent in English

Owns a smartphone

I have moderate to severe anxiety or depression.

Exclusion Criteria

History of bipolar disorder (based on the self-reported Mood Disorder Questionnaire [MDQ])

I have not changed my medications or treatments in the last 30 days.

Acute psychosis (based on the self-reported Structured Interview for Psychosis risk Syndromes, Prodromal Questionnaire - Brief version [SIPS PQ-B])

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the Mood Triggers app for personalized feedback on anxiety and depression triggers, with ultra-brief interventions delivered via videos

12 weeks

Follow-up

Participants are monitored for changes in depression and anxiety symptoms, as well as cancer risk, using various assessments

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Mood Triggers App

Trial Overview The study tests if using the Mood Triggers App on a smartphone can help reduce anxiety and depression symptoms in individuals at risk of cancer by providing mental health support.

How Is the Trial Designed?

Group I: MoodTriggers App Experimental Treatment 1 Intervention

Mood Triggers provides personalized feedback on individuals' maintenance factors (i.e., "triggers") of their anxiety and depressive symptoms based on the theory that such feedback will lead to symptom reduction. Mood Triggers delivers ultra-brief interventions (less than 2 minutes long) where participants view videos which introduce an important skill to treat their anxiety and depressive.

Who Is Running the Clinical Trial?

Trustees of Dartmouth College

Lead Sponsor

Trials

32

Recruited

14,500+

Norris Cotton Cancer Center

Collaborator

Trials

9

Recruited

1,700+